|
|
||||||||
1From the Departments of Ophthalmology and Visual Sciences, and the 2Anatomical Sciences and Neurobiology, and the 3James Graham Brown Cancer Center, University of Louisville School of Medicine, Louisville, Kentucky.
PURPOSE. Evidence supports the immune system activity accompanying glaucomatous neurodegeneration. This study aimed to determine the in vitro effects of reactive oxygen species (ROS) on the phenotype and antigen-presenting function of the retina and optic nerve head glia.
METHODS. Cultures of rat retina and optic nerve head glia were treated with a mixture of ROS-generating compounds for 24 and 48 hours. Pretreated glial cells were then coincubated with syngeneic CD4+ T cells for 48 hours. ROS generation and cell viability were assessed with the use of dihydroethidium and calcein assays, respectively. Flow cytometry and immunocytochemistry were used to determine major histocompatibility complex (MHC) class II molecules. In addition, functional experiments were performed to determine the proliferation and cytokine secretion of T cells using [3H]-thymidine incorporation and TNF-
assays, respectively.
RESULTS. MHC class II molecules were upregulated on glial cells exposed to ROS. Compared with the control glia, glial cells in ROS-generating systems were found to be more potent inducers of T-cell activation in a cell density- and time-dependent manner, as assessed by increased T-cell proliferation (approximately threefold) and TNF-
secretion (approximately sixfold; P < 0.01). When an ROS scavenging treatment was applied, MHC class II upregulation on glial cells persisted, but antigen-mediated T-cell activation was significantly decreased (P < 0.01), indicating an additional costimulatory function of ROS during antigen presentation.
CONCLUSIONS. These in vitro findings support that ROS regulate the immune response by stimulating the antigen-presenting ability of glial cells and functioning as costimulatory molecules for antigen presentation.
This article has been cited by other articles:
![]() |
A. J. Weber, C. D. Harman, and S. Viswanathan Effects of optic nerve injury, glaucoma, and neuroprotection on the survival, structure, and function of ganglion cells in the mammalian retina J. Physiol., September 15, 2008; 586(18): 4393 - 4400. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. Sappington and D. J. Calkins Contribution of TRPV1 to Microglia-Derived IL-6 and NF{kappa}B Translocation with Elevated Hydrostatic Pressure Invest. Ophthalmol. Vis. Sci., July 1, 2008; 49(7): 3004 - 3017. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Hollborn, M. Francke, I. Iandiev, E. Buhner, C. Foja, L. Kohen, A. Reichenbach, P. Wiedemann, A. Bringmann, and S. Uhlmann Early Activation of Inflammation- and Immune Response-Related Genes after Experimental Detachment of the Porcine Retina Invest. Ophthalmol. Vis. Sci., March 1, 2008; 49(3): 1262 - 1273. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |